An alternative explanation is the fact that these cells may perhaps serve to augment the immune suppression of viral replication or may perhaps reflect a more active antiviral response in other compartments for instance lymphoid or mucosal tissue
Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, et al. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J Biol Chem 267: 546554. Jan A, Gokce O, Luthi-Carter R, Lashuel HA The ratio of monomeric to aggregated types of Abeta40 and Abeta42 is definitely an critical determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity. J Biol Chem 283: 2817628189. Jarrett JT, Berger EP, Lansbury PT, Jr. The carboxy terminus of your beta amyloid protein is important for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32: 46934697. Scheuner D, Eckman C, Jensen M, Song X, Citron M, et al. We identified, on the other hand, that CTLA-4 and PD-1 cells from initial virologic suppressors created up a higher proportion of HIV-1 Gag-specific CD4 TNF-a T cells than those from non-suppressors Secreted amyloid beta-protein related to that within the senile plaques of Alzheimer's illness is improved in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med two: 864870. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, et al. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4: 97100. Borchelt DR, Lee MK, Gonzales V, Slunt HH, Ratovitski T, et al. Accumulation of proteolytic fragments of mutant presenilin 1 and accelerated amyloid deposition are co-regulated in transgenic mice. Neurobiol Aging 23: 171177. Radde R, Bolmont T, Kaeser SA, Coomaraswamy J, Lindau D, et al. Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep 7: 940946. 47. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, et al. Mutation of your beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 360: 672674. 48. Haass C, Lemere CA, Capell A, Citron M, Seubert P, et al. The Swedish mutation causes early-onset Alzheimer's disease by beta-secretase cleavage within the secretory pathway. Nat Med 1: 12911296. 49. Munter LM, Botev A, Richter L, Hildebrand PW, Althoff V, et al. Aberrant amyloid precursor protein processing in hereditary forms of Alzheimer illness brought on by APP familial Alzheimer disease mutations might be rescued by mutations inside the APP GxxxG motif. J Biol Chem 285: 2163621643. 50. Citron M, Eckman CB, Diehl TS, Corcoran C, Ostaszewski BL, et al. Additive effects of PS1 and APP mutations on secretion of the 42-residue amyloid beta-protein. Neurobiol Dis five: 107116. 51. Dumanchin C, Tournier I, Martin C, Didic M, Belliard S, et al. Biological effects of 4 PSEN1 gene mutations causing Alzheimer illness with spastic paraparesis and cotton wool plaques. Hum Mutat 27: 1063. 52. Kumar-Singh S, Theuns J, Van Broeck B, Pirici D, Vennekens K, et al. Imply age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both enhanced Abeta42 and decreased Abeta40. Hum Mutat 27: 686695. 53. Steiner H, Romig H, Grim MG, Philipp U, Pesold B, et al. The biological and pathological function from the presenilin-1 Deltaexon 9 mutation is independent of its defect to undergo proteolytic processing. J Biol Chem 274: 76157618. 54. Houlden H, Baker M, McGowan E, Lewis P, Hutton M, et al. Variant Alzheimer's disease with spastic paraparesis and cotton wool plaques is brought on by PS-1 mutations that lead to exceptionally higher amyloid-beta concentrations. Ann Neurol 48: 806808.
